@Article{Gniadecki2009,
journal="Dermatology Review/Przegląd Dermatologiczny",
issn="0033-2526",
volume="96",
number="6",
year="2009",
title="Primary cutaneous CD30+ lymphoproliferative disorders: how to diagnose and treat?",
abstract="Primary cutaneous CD30-positive T-cell lymphoproliferative disorders(pc-CD30+ LPD), which comprise primary cutaneous anaplastic large-cell lymphoma (pc-ALCL) and lymphomatoid papulosis (LyP), are the second most common group of cutaneous T-cell lymphomas. A definite clinical diagnosis is usually reached via the clinical-pathological correlation. The most important differential diagnoses for pc-CD30+ LPD are cutaneous metastases of systemic CD30+ lymphomas, pseudo-lymphomas with CD30+ expression, and large-cell transformation of mycosis fungoides. The prognosis is usually very good. Radiotherapy and low-dose oral methotrexate are the most effective therapies for pc-CD30+ LPD.",
author="Gniadecki, Robert
and Lech-Marańda, Ewa",
pages="377--380",
url="https://www.termedia.pl/Primary-cutaneous-CD30-lymphoproliferative-disorders-how-to-diagnose-and-treat-,56,13842,1,1.html"
}